StockData
XORTX Therapeutics Inc. logo

XORTX Therapeutics Inc. (XRTX) stock

XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 0/30
$1.06+0.02 (+1.92%)

Close on Nov 17, 2026Market cap $116.17KP/E –Yield –

XORTX Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

XORTX Therapeutics's enterprise value was $97.54K on Nov 11, 2026, against $355.99K a year earlier. Over the last 5 years it ranged from $97.54K to $1.39B, with a median of $17.78M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$97.54K-68.4%
2025Dec 31, 2025$308.56K-97.2%
2024Dec 31, 2024$11.19M-34.5%
2023Dec 29, 2023$17.09M-97.0%
2022Dec 30, 2022$570.25M–

More XORTX Therapeutics figures

See a number that looks wrong?